The p53 pathway: targets for the development of novel cancer therapeutics.

Cancer treatment and research

Volumn 119, Issue , 2004, Pages 175-187

  Wang, Shulin ^a   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; GENE THERAPY; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; DRUG DESIGN; GENE THERAPY; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

MLCS; MLOWN;

EID: 2942648713     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/1-4020-7847-1_9     Document Type: Review

References (82)